Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 902219 Boston, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,999,477
+$873,292 QoQ
Shares Held
164,716
+10.1% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 183 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 0% Shared 70% None 30%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. CGEM ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in CGEM

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,999,477 164,716
2026-03-31 $2,126,185 149,626
2025-12-31 $1,653,422 159,751
2025-09-30 $997,015 168,131
2025-06-30 $1,401,203 186,083
2025-03-31 $1,219,201 161,057
2024-12-31 $1,619,646 132,976
2024-09-30 $1,774,857 106,025
2024-06-30 $1,257,388 72,098
2024-03-31 $1,164,819 68,358
2023-03-31 $277,457 27,122
2022-12-31 $283,699 26,891
2022-09-30 $337,601 26,334
2022-06-30 $343,562 26,799
2022-03-31 $276,365 26,396
2021-12-31 $687,745 44,572
2021-03-31 $6,439,638 154,539